Support: The filming of this video was supported by Cellnovo Ltd.
FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016
WHY IS THE PREVALENCE OF INSULIN PUMP THERAPY SO LOW IN THE UK?
00:09 - Because we’ve been slow adopters of pumps, back in the 1980s when pumps were very new technology, the UK was involved in several of the early clinical trials, and I think the technology wasn’t sort of sufficiently good to deliver the tiny doses of insulin that pumps deliver to patients. So I think at the start, that left maybe a bad taste in the mouths of senior clinicians in the UK, and that’s taken some overcoming. I think, in addition to that, there’s also been the cost issues within the NHS that has led to slower adoption than in other countries; in Europe and in the United States.
IS THE PERCEPTION OF INSULIN PUMP THERAPY CHANGING AMONG UK CLINICIANS?
00:49 – I think the perception is changing. I think it’s being driven in two main areas, one in paediatrics, so children with type 1 diabetes, and secondly in pregnancy. And I think, as the support in terms of diabetes specialist nurses has improved in paediatrics and for pregnancy, so the adoption of these new technologies is becoming more common. And I think, ultimately, that will drive the increased use of pumps in the adult population in the UK.